U.S. FDA considering lowering recommended age for Pfizer/BioNTech COVID-19 boosters
Go back to U.S. FDA considering lowering recommended age for Pfizer/BioNTech COVID-19 boosters| (NASDAQ: BNTX) | Delayed: 99.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $99.08 | 52 Week High | $ | |||
| Open | $99.08 | 52 Week Low | $ | |||
| Day High | $99.08 | P/E | N/A | |||
| Day Low | $99.08 | EPS | $ | |||
| Volume | 19,179 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.72 | 52 Week High | $37.39 | |||
| Open | $28.72 | 52 Week Low | $28.25 | |||
| Day High | $28.72 | P/E | 17.41 | |||
| Day Low | $28.72 | EPS | $1.65 | |||
| Volume | 194,114 | |||||
